The Risks and Benefits of Reoperation Aortic Valve Replacement

Slides:



Advertisements
Similar presentations
Some Surgical Aspects of Atrial Fibrillation
Advertisements

STS 2015 John V. Conte, MD Professor of Surgery Johns Hopkins University School of Medicine On Behalf of the CoreValve US Investigators Transcatheter Aortic.
PARTNER Objective To compare surgical aortic valve replacement (AVR) with transcatheter aortic valve replacement (TAVR) in high-risk patients with severe.
© 2012 EuroIntervention. All rights reserved. EuroIntervention 2009;5: A comparison of patient characteristics and 30-day mortality outcomes after.
Comprehensive Cerebral Protection During Operations Involving the Aortic Arch Vincent Gaudiani, MD, Paul Shuttleworth, CCP Luis Castro, MD, Audrey Fisher,
Patient disposition Dichtl W, et al. Am J Cardiol. 2008;102:743-8 AVR = aortic valve replacement; MDCT = multidetector computed tomographic.
Todd M. Dewey, MD, David L. Brown, MD, Tony S. Das, MD, William H
Surgical aspects of MV replacement: New options with mechanical valves
A Meta-Analysis of Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement  Hisato Takagi, MD, PhD, Masao Niwa, MD, Yusuke Mizuno,
Ruyun Jin, MD, Gary L. Grunkemeier, PhD, Albert Starr, MD 
Volume 95, Issue 1, Pages (January 1989)
Transcatheter aortic valve replacement in patients with severe aortic stenosis who are at high risk for surgical complications: Summary assessment of.
Twenty-Five Year Experience With the St
Clinical experience with the carbomedics valve: Early results with a new bileaflet mechanical prosthesis  J.Francisco Nistal, MD, Aquilino Hurlé, MD,
Influence of the On-X mechanical prosthesis on intermediate-term major thromboembolism and hemorrhage: A prospective multicenter study  Vincent Chan,
Mechanical Versus Bioprosthetic Aortic Valve Replacement in Middle-Aged Adults: A Systematic Review and Meta-Analysis  Dong Fang Zhao, BA, Michael Seco,
Long-term durability of Edwards bioprosthetic aortic valves
Junya Sugiura, MD, Toshihide Nakano, MD, Hideaki Kado, MD 
Risk factors for atherosclerosis and the degeneration of pericardial valves after aortic valve replacement  Georg Nollert, MD, Jessica Miksch, MD, Eckart.
Reoperative minimal access aortic valve surgery: Minimal mediastinal dissection and minimal injury risk  Minoru Tabata, MD, MPH, Zain Khalpey, MD, PhD,
Sorin Bicarbon: 17 years of clinical use
Reoperative aortic valve replacement in the octogenarians—minimally invasive technique in the era of transcatheter valve replacement  Tsuyoshi Kaneko,
Effect of Race on the Incidence of Aortic Stenosis and Outcomes of Aortic Valve Replacement in the United States  Fahad Alqahtani, MD, Sami Aljohani,
Five-Year Follow-up After Heart Valve Replacement With the CarboMedics Bileaflet Prosthesis  Suzanne M. Rödler, MD, Anton Moritz, MD, Wolfgang Schreiner,
Reply The Annals of Thoracic Surgery
YingXing Wu, MD, Ruyun Jin, MD, Guangqiang Gao, MD, Gary L
Usefulness of microsimulation to translate valve performance into patient outcome: Patient prognosis after aortic valve replacement with the Carpentier–Edwards.
A 10-Year Experience With the Carbomedics Cardiac Prosthesis
John M. Fallon, MD, Joseph P. DeSimone, MD, J
Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: Changes in risks, valve types, and outcomes in the Society.
G. James Avery, MD, S. Jill Ley, RN, J
W. R. Eric Jamieson, MD, Guy J. Fradet, MD, James G
Shikhar Agarwal, MD, MPH, Aatish Garg, MD, Akhil Parashar, MD, Lars G
Surgical Management of Aortic Regurgitation Associated With Takayasu Arteritis and Other Forms of Aortitis  Osamu Adachi, MD, Yoshikatsu Saiki, MD, Junetsu.
Ruyun Jin, MD, Gary L. Grunkemeier, PhD, Albert Starr, MD 
Patient outcome after aortic valve replacement with a mechanical or biological prosthesis: Weighing lifetime anticoagulant-related event risk against.
Change in symptoms in operated and unoperated patients 1 year following evaluation of surgical AVR. Pie charts display change from baseline to follow-up.
The Midterm Impact of Transcatheter Aortic Valve Replacement on Surgical Aortic Valve Replacement in Michigan  Himanshu J. Patel, MD, Morley A. Herbert,
Sam Chitsaz, MD, Nicolas Jaussaud, MD, Edward Chau, MD, Kimberly S
Hsin-Fang Li, PhD, YingXing Wu, MD, Mansen Wang, PhD, Gary L
Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement  Ole Lund, MD, PhD, Martin Bland,
YingXing Wu, MD, Eric G. Butchart, FRCS, Jeffrey S
Andreas Zierer, MD, Rochus K. Voeller, MD, Karen E
Nancy J. O Birkmeyer, PhD, John D Birkmeyer, MD, Anna N
Does the degree of preoperative mitral regurgitation predict survival or the need for mitral valve repair or replacement in patients with anomalous origin.
Alexander Kulik, MD, Manal Al-Saigh, MD, Vincent Chan, MD, Roy G
Long-term evaluation of biological versus mechanical prosthesis use at reoperative aortic valve replacement  Vincent Chan, MD, MPH, B-Khanh Lam, MD, MPH,
Transcatheter aortic valve replacement in intermediate-risk patients
Mechanical heart valves: are two leaflets better than one?
Robert W. Emery, MD, Christopher C. Krogh, Kit V. Arom, MD, PhD, Ann M
Conventional redo biological valve replacement over 20 years: Surgical benchmarks should guide patient selection for transcatheter valve-in-valve therapy 
Nilto Carias de Oliveira, MD, Tirone E
Mechanical Versus Bioprosthetic Aortic Valve Replacement in Middle-Aged Adults: A Systematic Review and Meta-Analysis  Dong Fang Zhao, BA, Michael Seco,
Junya Sugiura, MD, Toshihide Nakano, MD, Hideaki Kado, MD 
Aortic root replacement with composite valve graft
Thirty-year experience with a bileaflet mechanical valve prosthesis
Influence of experience and the surgical learning curve on long-term patient outcomes in cardiac surgery  Bryan M. Burt, MD, Andrew W. ElBardissi, MD,
Arnt E Fiane, MD, Odd R Geiran, MD, PhD, Jan L Svennevig, MD, PhD 
Hartzell V Schaff, MD, Thierry P Carrel, MD, W. R
Richard P Anderson, MD, Ruyun Jin, MD, Gary L Grunkemeier, PhD 
Todd M. Dewey, MD, David L. Brown, MD, Tony S. Das, MD, William H
YingXing Wu, MD, Gary L. Grunkemeier, PhD, Albert Starr, MD 
Long-term clinical experience with the omnicarbon prosthetic valve
Routine enlargement of the small aortic root: a preventive strategy to minimize mismatch  Luis J Castro, MD, Joseph M Arcidi, MD, Audrey L Fisher, BS,
Gary L Grunkemeier, PhD, Ruyun Jin, MD  The Annals of Thoracic Surgery 
Durability of pericardial versus porcine bioprosthetic heart valves
Transcatheter aortic valve implantation versus surgical aortic valve replacement: A propensity score analysis in patients at high surgical risk  Lenard.
Risk of Valve-Related Events After Aortic Valve Repair
Thanos Sioris, MD, Tirone E
Presentation transcript:

The Risks and Benefits of Reoperation Aortic Valve Replacement Vincent Gaudiani, MD Gary Grunkemeier, PhD Luis Castro, MD Audrey Fisher, MPH YingXing Wu, MD

The Risks and Benefits of Reoperation Aortic Valve Replacement Objectives Compare the surgical risks of first time AVR vs. re-operative AVR in 1213 consecutive unselected patients. Determine the risk factors that predict mortality in this series. Assess the clinical risk of reoperation AVR compared to long term anticoagulation. The Risks and Benefits of Reoperation Aortic Valve Replacement

Risk of Anticoagulation Related Hemorrhage The composite linearized rate of anticoagulation related hemorrhage in several large series averages 0.9 – 2.5% per year. Akins, Ann Thor Surg 61:806, 1996 The Risks and Benefits of Reoperation Aortic Valve Replacement

The Risks and Benefits of Reoperation Aortic Valve Replacement Patient Demographics   First Op (n=887) Reop (n=326) p-value Age 71 69 .004 Female  43% 31% <.001 Renal Failure 7% 13% .005 Stroke 8% 11% NS Diabetes  19% 23% PVD  17% 26% .001 COPD 18% 19% The Risks and Benefits of Reoperation Aortic Valve Replacement

* Statistically significant at p<.05 Age Histogram: First Operation vs. Reoperation * First Op Age Avg = 71 Reop Avg Age = 69 * Statistically significant at p<.05 The Risks and Benefits of Reoperation Aortic Valve Replacement

The Risks and Benefits of Reoperation Aortic Valve Replacement Prostheses Types First Operation (n=887) Reoperation (n=326) The Risks and Benefits of Reoperation Aortic Valve Replacement

Prior Cardiac Operations in Reoperative AVR’s (n=326) The Risks and Benefits of Reoperation Aortic Valve Replacement

The Risks and Benefits of Reoperation Aortic Valve Replacement Cardiac Findings   First Op (n=887) Reop (n=326) p-value Ejection Fraction 52% 46% <.001 NYHA 3+  67%  82% Congestive Heart Failure 75% 82% .010 Angina 30% 48% MI  5% 6% NS Hypertension 63% 58% Endocarditis Active 1% 4% .037 Treated 2% 7% .001 The Risks and Benefits of Reoperation Aortic Valve Replacement

The Risks and Benefits of Reoperation Aortic Valve Replacement Coronary Disease   First Op (n=887) Reop (n=326) p-value # Diseased Vessels  None 56% 44% <.001 Single 14% 8% .001 Double 12% .043 Triple 18% 40% The Risks and Benefits of Reoperation Aortic Valve Replacement

Concomitant Procedures   First Op (n=887) Reop (n=326) p-value Coronary Artery Bypass  36% 39% NS Mitral Valve Repair 3% Mitral Valve Replacement 9% 20% <.001 Tricuspid Valve Procedure  1% 6% The Risks and Benefits of Reoperation Aortic Valve Replacement

The Risks and Benefits of Reoperation Aortic Valve Replacement Operative Status   First Op (n=887) Reop (n=326) p-value Status Elective 70% 56% <.001 Urgent 28% 42% Emergent 2% NS The Risks and Benefits of Reoperation Aortic Valve Replacement

The Risks and Benefits of Reoperation Aortic Valve Replacement Operative Times   First Op (n=887) Reop (n=326) p-value Perfusion Time (min)  85 99 <.001 Clamp Time (min) 67 78 The Risks and Benefits of Reoperation Aortic Valve Replacement

The Risks and Benefits of Reoperation Aortic Valve Replacement Operative Results   First Op (n=887) Reop (n=326) p-value Operative Death  4.1% 3.1% NS Cerebrovascular Accident  4.7% 4.0% Vent > 24h  11.9% 16.3% Reexploration for bleed  4.6% 5.2% Complete Heart Block 7.7% 9.8% Renal Failure 3.4% 6.7% .027 Postop LOS  8.4 9.7 <.001 The Risks and Benefits of Reoperation Aortic Valve Replacement

The Risks and Benefits of Reoperation Aortic Valve Replacement Factors Predicting Mortality by Multivariate Logistic Regression (p<0.10) Factor p-value Odds Ratio Preop Dialysis 0.004 6.61 Preop Cardiogenic Shock 0.001 4.94 NYHA Class IV 0.070 1.93 Female 0.071 1.85 Perfusion Time 0.005 1.11 Age 0.023 1.04 The Risks and Benefits of Reoperation Aortic Valve Replacement

The Risks and Benefits of Reoperation Aortic Valve Replacement Mortality by Age Group The Risks and Benefits of Reoperation Aortic Valve Replacement

The Risks and Benefits of Reoperation Aortic Valve Replacement Mortality by Age Group The Risks and Benefits of Reoperation Aortic Valve Replacement

The Risks and Benefits of Reoperation Aortic Valve Replacement Conclusions The risks of re-operative AVR are low The risks of long-term anticoagulation are known We encourage all adult patients to choose the risks and benefits of tissue vs. mechanical AVR based upon a thorough discussion of these risks The Risks and Benefits of Reoperation Aortic Valve Replacement

The Risks and Benefits of Reoperation Aortic Valve Replacement Prosthesis Selection “ The choice of one type of valve versus the other is largely based on the surgeons’ or cardiologists’ views on what is the least harmful for the patient-anticoagulation for life, or the risk of reoperation.” Tirone E. David, M.D. Toronto General Hospital The Risks and Benefits of Reoperation Aortic Valve Replacement

The Risks and Benefits of Reoperation Aortic Valve Replacement Patient Demographics First Op Redo Isolated 1st Op Isolated Redo Redo Prev AVR Redo Prev Other N 887 326 376 55 134 192 Age 71.1 68.7 69.2 58.8 64.1 71.8 Female   43.1% 30.7% 41.3% 21.8% 29.9% 31.3% Renal Failure 7.3% 13.2% 4.8% 12.7% 13.4% 13.0% Stroke 7.7% 10.7% 6.1% 16.4% 10.4% 10.9% Diabetes 19.3% 22.7% 14.1% 29.2% PVD 16.9% 26.4% 9.3% 14.9% 34.4% COPD 18.0% 18.7% 16.8% 19.4% 18.2% The Risks and Benefits of Reoperation Aortic Valve Replacement

The Risks and Benefits of Reoperation Aortic Valve Replacement Cardiac Findings   First Op Redo Isolated 1st Op Isolated Redo Redo Prev AVR Redo Prev Other N 887 326 376 55 134 192 EF 51.6% 46.4% 53.0% 51.8% 50.0% 44.0% NYHA III 38.9% 42.6% 38.8% 34.5% 43.3% 42.2% IV 27.7% 40.2% 18.6% 30.9% 34.3% 44.3% CHF 75.2% 81.9% 72.6% 85.5% 82.1% 81.8% Angina 29.9% 48.0% 3.4% 16.7% 45.5% MI 4.7% 6.1% 1.1% 0.0% 2.2% 8.9% Hypertension 63.1% 58.3% 56.6% 49.1% 46.3% 66.7% Endocarditis Active 1.4% 3.7% 1.9% 9.1% 7.5% 1.0% Treated 2.0% 7.4% 2.1% 20.0% 16.4% The Risks and Benefits of Reoperation Aortic Valve Replacement

The Risks and Benefits of Reoperation Aortic Valve Replacement Coronary Disease   First Op Redo Isolated 1st Op Isolated Redo Redo Prev AVR Redo Prev Other N 887 326 376 55 134 192 # Diseased Vessels None 55.8% 44.2% - 63.4% 30.7% Single 14.2% 7.7% 14.9% 2.6% Double 11.7% 8.0% 8.2% 7.8% Triple 18.3% 40.2% 13.4% 58.9% The Risks and Benefits of Reoperation Aortic Valve Replacement

Prior Cardiac Operations   First Op Redo Isolated 1st Op Isolated Redo Redo Prev AVR Redo Prev Other N 887 326 376 55 134 192 # Prior Cardiac Operations 1 - 75.2% 74.5% 73.9% 76.0% 2 18.7% 14.5% 20.1% 17.7% 3 5.2% 9.1% 4 0.9% 1.8% 0.7% 1.0% The Risks and Benefits of Reoperation Aortic Valve Replacement

Concomitant Procedures   First Op (887) Redo (326) Isolated 1st Op (376) Isolated Redo (55) Redo Prev AVR (134) Redo Prev Other (192) N 887 326 376 55 134 192 CAB 36.2% 38.7% - 25.4% 47.9% MVV 3.0% 3.1% MVR 9.4% 19.6% 23.1% 17.2% TV 1.1% 6.4% 8.2% 5.2% The Risks and Benefits of Reoperation Aortic Valve Replacement

The Risks and Benefits of Reoperation Aortic Valve Replacement Operative Status   First Op Redo Isolated 1st Op Isolated Redo Redo Prev AVR Redo Prev Other N 887 326 376 55 134 192 Status Elective 69.9% 55.5% 78.5% 61.8% 57.5% 54.2% Urgent 28.3% 42.3% 20.5% 34.5% 39.6% 44.3% Emergent 1.6% 2.1% 1.1% 3.6% 3.0% The Risks and Benefits of Reoperation Aortic Valve Replacement

The Risks and Benefits of Reoperation Aortic Valve Replacement Operative Times   First Op Redo Isolated 1st Op Isolated Redo Redo Prev AVR Redo Prev Other N 887 326 376 55 134 192 Perfusion Time (min) 85 99 69 77 102 97 Clamp Time (min) 67 78 53 63 82 76 The Risks and Benefits of Reoperation Aortic Valve Replacement

The Risks and Benefits of Reoperation Aortic Valve Replacement Operative Results   First Op Redo Isolated 1st Op Isolated Redo Redo Prev AVR Redo Prev Other N 887 326 376 55 134 192 Operative Death  4.1% 3.1% 3.2% 1.8% 3.0% CVA  4.7% 4.0% 3.5% 2.2% 5.2% Vent > 24h  11.9% 16.3% 5.1% 12.7% 13.4% 18.2% Reexplore for bleed  4.6% 2.9% 5.5% 6.0% 4.7% Complete Heart Block 7.7% 9.8% 7.3% 9.7% 9.9% Renal Failure 3.4% 6.7% 2.4% 4.5% 8.3% Postop LOS  8.4 9.7 7.0 7.1 8.6 10.4 The Risks and Benefits of Reoperation Aortic Valve Replacement